Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06301347
Other study ID # LTP+P
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 1, 2024
Est. completion date December 30, 2025

Study information

Verified date May 2024
Source Pakistan Institute of Living and Learning
Contact Tayyeba Kiran, PhD
Phone 0923328262142
Email tayyebakiran@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evidence reports that parents with schizophrenia are particularly vulnerable to parenting difficulties and also experience problems in sensitively interacting with their children. This may cause insecure attachment in infants of mothers with psychosis. Children of parents with schizophrenia have poor developmental and clinical outcomes. However, there is no published trial, to the best of our knowledge, for children of parents with schizophrenia. Learning through Play (LTP) is a potentially low cost intervention to improve maternal mental health and child outcomes by promoting health child development. The proposed study will integrate LTP with existing culturally appropriate Cognitive Behaviour Theray (CBT) for psychosis (CaCBT-p) and test its feasibility and acceptability for parents with schizophrenia.


Description:

Objectives - To determine whether the proposed intervention is acceptable to the parents with schizophrenia. - To assess the feasibility of proposed intervention for target population (no of sessions attended, content, duration and location, uptake and retention). - To determine most suitable outcome measures for future randomized controlled trial. - To identify any barriers in recruitment of participants. Recruiting up to 75% of total sample will be a success criteria. Methods Design: Mixed method feasibility Randomised Controlled Trial Study Sites The participants will be recruited from outpatient departments of psychiatry and community settings in 7 cities of Pakistan i.e. Karachi, Hyderabad, Lahore, Rawalpindi, Multan, Peshawar and Quetta. Sample Size: A total of 90 individuals (45 in each arm) meeting the eligibility criteria will be recruited to participate in the study from different psychiatric units. Randomization Participants will be randomized into one of the two treatment conditions (LTP Plus or TAU) through computer generated algorithm.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date December 30, 2025
Est. primary completion date April 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diagnostic and Statistical Manual-V (DSM-V) diagnosed first episode psychosis, schizophrenia, schizoaffective disorder, psychosis not otherwise specified or schizophreniform disorder. - Parents (Mother or Father), age 18 year and above - Parents (Mother or Father) having a child from birth to 36 months - Parents (Mother or Father) living within the catchment area of recruitment site. - Competent and willing to give informed consent - Parents (Mother or Father) are stable on medication for at least 3 months prior to the intervention. Exclusion Criteria: - Violation of any inclusion criteria - Failure to perform screening or baseline examinations. - Patients who will meet the criteria for a DSM-V diagnosis of alcohol or substance abuse (other than for nicotine) within the last month or the criteria for DSM-V alcohol or substance dependence (other than for nicotine) within the last 6 months - Temporary resident unlikely to be available for follow up.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Learning through Play Plus
Combination of two interventions: Learning through Play and Cognitive Behaviour Therapy

Locations

Country Name City State
Pakistan Karwan e hayat Karachi Sindh

Sponsors (1)

Lead Sponsor Collaborator
Pakistan Institute of Living and Learning

Country where clinical trial is conducted

Pakistan, 

References & Publications (4)

Husain MI, Chaudhry IB, Khoso AB, Wan MW, Kiran T, Shiri T, Chaudhry N, Mehmood N, Jafri SF, Naeem F, Husain N. A Group Parenting Intervention for Depressed Fathers (LTP + Dads): A Feasibility Study from Pakistan. Children (Basel). 2021 Jan 6;8(1):26. doi — View Citation

Husain MO, Chaudhry IB, Mehmood N, Rehman RU, Kazmi A, Hamirani M, Kiran T, Bukhsh A, Bassett P, Husain MI, Naeem F, Husain N. Pilot randomised controlled trial of culturally adapted cognitive behavior therapy for psychosis (CaCBTp) in Pakistan. BMC Healt — View Citation

Husain N, Kiran T, Fatima B, Chaudhry IB, Husain M, Shah S, Bassett P, Cohen N, Jafri F, Naeem S, Zadeh Z, Roberts C, Rahman A, Naeem F, Husain MI, Chaudhry N. An integrated parenting intervention for maternal depression and child development in a low-res — View Citation

Husain N, Zulqernain F, Carter LA, Chaudhry IB, Fatima B, Kiran T, Chaudhry N, Naeem S, Jafri F, Lunat F, Haq SU, Husain M, Roberts C, Naeem F, Rahman A. Treatment of maternal depression in urban slums of Karachi, Pakistan: A randomized controlled trial ( — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment Rate The number of parent-child dyads referred by the community health workers/treating psychiatrists, the parents who consented from all eligible parent-child dyads Change in numbers from first month of recruitment to last month of recruitment (total recruitment period is 12 months)
Primary Attrition Rate The number participants withdrawn out of those consented to participate Change in numbers from first month of randomisation to last month of outcome assessments (total time period is 18 months).
Primary Intervention attendance log This log will be maintained to assess the acceptability of the intervention is defined as "the extent participant receiving the intervention consider it to be appropriate" number of sessions attended by each participant in 12 month time
Secondary Positive and Negative Syndrome Scale This is a structured clinical interview consisting of 30 items designed to assess severity of symptoms over the past week on a 7-point scale. Higher score indicates more severe psychopathology. Change in scores from baseline to 3-month post-randomisation
Secondary Psychotic Rating Scale This scale rates features such as frequency, intensity, and interference of hallucinations and delusions on a 4-point scale. Higher score indicates more severe psychopathology. Change in scores from baseline to 3-month post-randomisation
Secondary Parenting Stress Index This is a a five-point scale to assess (1) Parenting Distress, (2) Difficult Child Characteristics, and (3) Dysfunctional Parent-Child Interaction. Higher score indicates higher intensity of parenting stress. Change in scores from baseline to 3-month post-randomisation
Secondary Maternal Attachment Inventory A 26-item scale will be used to ask respondents to indicate how they generally feel in relation to thoughts (e.g. 'My thoughts are full of my baby'), feelings (e.g. 'I feel love for my baby') and situations (e.g. 'I watch my baby sleep') new mothers may experience. Higer score indicate greater level of maternal attachment. Change in scores from baseline to 3-month post-randomisation
Secondary Knowledge attitude and practices of Child Development A 20-item questionnaire will be used to assess maternal knowledge and expectations for child development in the first three years. Higher score indicate better knowledge about child development. Change in scores from baseline to 3-month post-randomisation
Secondary Calgary Depression Scale This is a depression rating scale especially developed for assessing depression in schizophrenia. Higher scores indicate higher depressive symptom severity. Change in scores from baseline to 3-month post-randomisation
Secondary Social and Occupational Functioning Scale It is a global rating of current functioning; this instrument focuses on social and occupational functioning that is independent of the overall severity of the individual's psychological symptoms. Higher score indicate better functioning. Change in scores from baseline to 3-month post-randomisation
Secondary Euro-Qol 5 Dimensions A standardized tool assessing the five health related quality of life aspects such as mobility, self-care, typical activates, pain and discomfort and anxiety/depression. Higher score indicate better quality of life. Change in scores from baseline to 3-month post-randomisation
Secondary Client Service Receipt Inventory this instrument is used to gather information about the complete spectrum of services and assistance that study participants might utilize Change in scores from baseline to 3-month post-randomisation
Secondary Ages and Stages Questionnaire parent-reported screening instrument comprising of 25/29 items focusing social and emotional challenges, Higher score indicate better development. Change in scores from baseline to 3-month post-randomisation
Secondary Manchester Assessment of Caregiver-Infant Interaction Six-minute videos of caregiver-infant interaction will be evaluated for a subset of participants by a trained, reliable rater on 7 MACI scales which globally assess core characteristics of caregiver-infant play interaction on a 7-point scale. Higher score indicate better interaction. Change in scores from baseline to 3-month post-randomisation
Secondary Bayley Scale of infant development Bayley Scale will be administered on a subset of participants to assess the motor (fine and gross), language (receptive and expressive), and cognitive development of infant and toddlers, ages 0-3. Higher score indicate better development. Change in scores from baseline to 3-month post-randomisation
Secondary Child Height Child height will be assessed in centimetres Change in scores from baseline to 3-month post-randomisation
Secondary Child Weight Child weight will be assessed in KGs Change in scores from baseline to 3-month post-randomisation
Secondary Child head circumference This will be assessed in centimetres Change in scores from baseline to 3-month post-randomisation
See also
  Status Clinical Trial Phase
Recruiting NCT04929938 - Application of UP for Transdiagnostic Treatment of Emotional Disorders for UHR for Psychosis Patients N/A
Recruiting NCT05863572 - Strengthening Care in Collaboration With People With Lived Experience of Psychosis in Uganda N/A
Completed NCT04277585 - Improving Access to Early Psychosis Coordinated Specialty Care N/A
Recruiting NCT06197048 - Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Recruiting NCT05769933 - Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
Recruiting NCT04298450 - ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention N/A
Not yet recruiting NCT05558332 - Youth Nominated Support Team N/A
Not yet recruiting NCT05358457 - Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf) N/A
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Completed NCT02895269 - COllaborative Shared Care to IMprove Psychosis Outcome N/A
Recruiting NCT02622048 - Understanding and Helping Families: Parents With Psychosis N/A
Completed NCT02653729 - Cbt for Psychosis and Affect on Psychosis Symptoms Phase 2
Completed NCT02531243 - Computer-Aided Learning for Managing Stress N/A
Completed NCT02733575 - Compassion Focused Therapy for Distressing Experiences N/A
Not yet recruiting NCT02244970 - Mindfulness RCT for Early Psychosis N/A
Enrolling by invitation NCT01364818 - Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment N/A
Withdrawn NCT00786318 - Ziprasidone vs Standard Therapy for Agitated Patients in the ED Phase 4
Recruiting NCT00722163 - A Randomized Controlled Trial of Individual Therapy for First Episode Psychosis Phase 0